, Tracking Stock Market Picks
Enter Symbol:
Gopro Inc. (GPRO) [hlAlert]

up 11.22 %

Gopro Inc. (GPRO) rated Buy with price target $13 by Dougherty & Company

Posted on: Thursday,  Jan 14, 2016  1:25 PM ET by Dougherty & Company

Dougherty & Company rated Buy Gopro Inc. (NASDAQ: GPRO) on 01/14/2016. Previously Dougherty & Company rated Buy Gopro Inc. (NASDAQ:
GPRO) on 03/30/2015., when the stock price was $42.94. Since then, Gopro Inc. has gained 11.22% as of 01/14/2016's recent price of $47.76.
If you would have followed the previous Dougherty & Company 's recommendation on GPRO, you would have gained 11.22% of your investment in 290 days.

Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Team The research group is composed of five senior analysts and two associate analysts. The senior analysts collectively have 44 years of securities industry experience, and include 3 MBA's, 2 CPA's, 2 PE's (professional engineer), a CFA and a CMA. The team has come together out of a passion for overlooked or misunderstood investment opportunities – generally in smaller-cap companies – and a love of in-depth research, with special emphasis on independent information sources and innovative thinking. Coverage Our research coverage is idea driven and balances the twin demands of opportunism for flexibility and universe consistency for maximization of information sources. Current sub-sectors of interest include: * Specialty retail * Internet security * Internet media * Auto-identification and data capture (AIDC & RFID) * Mobile computing * Specialty manufacturing * Chronic care management * Outpatient services * Medical devices * Healthcare IT
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2016 1:25 PM Buy
12.42 13.00
as of 8/27/2015
1 Week down  -24.26 %
1 Month down  -15.85 %
3 Months down  -5.64 %
1 YTD down  -21.71 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2015 12:25 PM Buy
25.91 30.00
7/22/2015 12:25 PM Buy
61.01 70.00
3/30/2015 12:25 PM Buy
42.94 55.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy